Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder

References

• Substance Abuse and Mental Health Services Administration (SAM-HSA), Center for Behavioral Health Statistics and QualityKey Substance Use and Mental Health Indicators in the United States: Results from the 2015 National Survey on Drug Use and HealthRockville, MDSubstance Abuse and Mental Health Services Administration2016HHS Publication No. SMA 16-4984, NSDUH Series H-51
   Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders-DSM-55th edWashington, DCAmerican Psychiatric Publishing2013
   Google Scholar
• RuddRAAleshireNZibbellJEGladdenRMIncreases in drug and opioid overdose deaths – United States, 2000–2014MMWR Morb Mortal Wkly Rep20166450–511378138226720857
   PubMed Web of Science ®Google Scholar
• BirnbaumHGWhiteAGSchillerMWaldmanTClevelandJMRolandCLSocietal costs of prescription opioid abuse, dependence, and misuse in the United StatesPain Med201112465766721392250
   PubMed Web of Science ®Google Scholar
• HansenRNOsterGEdelsbergJWoodyGESullivanSDEconomic costs of nonmedical use of prescription opioidsClin J Pain201127319420221178601
   PubMed Web of Science ®Google Scholar
• FlorenceCSZhouCLuoFXuLThe economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013Med Care2016541090190627623005
   PubMed Web of Science ®Google Scholar
• WhiteAGBirnbaumHGMarevaMNDirect costs of opioid abuse in an insured population in the United StatesJ Manag Care Pharm200511646947915998164
   PubMedGoogle Scholar
• StrasselsSAEconomic burden of prescription opioid misuse and abuseJ Manag Care Pharm200915755656219739878
   PubMed Web of Science ®Google Scholar
• McAdam-MarxCRolandCLClevelandJOderdaGMCosts of opioid abuse and misuse determined from a Medicaid databaseJ Pain Palliat Care Pharmacother201024151820345194
   PubMedGoogle Scholar
• OderdaGMLakeJRudellKRolandCLMastersETEconomic burden of prescription opioid misuse and abuse: a systematic reviewJ Pain Palliat Care Pharmacother201529438840026654413
   PubMedGoogle Scholar
• KampmanKJarvisMAmerican Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid useJ Addict Med20159535836726406300
   PubMed Web of Science ®Google Scholar
• McCance-KatzEFOffice-based buprenorphine treatment for opioid-dependent patientsHarv Rev Psychiatry200412632133815764468
   PubMed Web of Science ®Google Scholar
• ParranTVAdelmanCAMerkinBLong-term outcomes of office-based buprenorphine/naloxone maintenance therapyDrug Alcohol Depend20101061566019717249
   PubMed Web of Science ®Google Scholar
• TkaczJSevertJCacciolaJRuetschCCompliance with buprenorphine medication-assisted treatment and relapse to opioid useAm J Addict2012211556222211347
   PubMed Web of Science ®Google Scholar
• TkaczJVolpicelliJUnHRuetschCRelationship between buprenorphine adherence and health service utilization and costs among opioid dependent patientsJ Subst Abuse Treat201446445646224332511
   PubMed Web of Science ®Google Scholar
• RuetschCTkaczJNadipelliVRHeterogeneity of nonadherent buprenorphine patients: subgroup characteristics and outcomesAm J Manag Care2017236e172e17928817294
   PubMed Web of Science ®Google Scholar
• Lo-CiganicWHGelladWFGordonAJAssociation between trajectories of buprenorphine treatment and emergency department and in-patient utilizationAddiction2016111589290226662858
   PubMed Web of Science ®Google Scholar
• IBM Watson Health [webpage on the Internet]Truven Health Analytics®, part of the IBM Watson Health™ businessMarketScan Commercial Claims and Encounters Research Database, 2007–2015 [Data file]. Available from: http://truvenhealth.com/markets/life-sciences/products/data-tools/marketscan-databasesAccessed July 10, 2018
   Google Scholar
• IBM Watson Health [webpage on the Internet]Truven Health Analytics®, part of the IBM Watson Health™ businessMarketScan Medicaid Multi-State Research Database, 2007–2015 [Data file]. Available from: http://truvenhealth.com/markets/life-sciences/products/data-tools/marketscan-databasesAccessed July 10, 2018
   Google Scholar
• Nau DP [webpage on the Internet]Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication AdherenceAlexandria, VirginiaPharmacy Quality Alliance2017 Available from: http://pqaalliance.org/resources/adherence.aspAccessed August 30, 2017
   Google Scholar
• ClarkRESamnalievMBaxterJDYoungGYThe evidence doesn’t justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphineHealth Aff201130814251433
   Web of Science ®Google Scholar
• ClarkREBaxterJDAwehGO’ConnellEFisherWHBartonBARisk factors for relapse and higher costs among Medicaid members with opioid dependence or abuse: opioid agonists, comorbidities, and treatment historyJ Subst Abuse Treat201557758025997674
   PubMed Web of Science ®Google Scholar
• DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9 CM administrative databasesJ Clin Epidemiol19924566136191607900
   PubMed Web of Science ®Google Scholar
• FareedAVayalapalliSCasarellaJDrexlerKEffect of buprenorphine dose on treatment outcomesJ Addict Dis201231181822356665
   PubMed Web of Science ®Google Scholar
• KhemiriAKharitonovaEZahVRubyJToumiMAnalysis of buprenorphine/naloxone dosing impact on treatment duration, resource use and costs in the treatment of opioid-dependet adults: a retrospective study of US public and private health care claimsPostgrad Med2014126511312025295655
   PubMed Web of Science ®Google Scholar
• HessKRGraphical methods for assessing violations of the proportional hazards assumption in Cox regressionStat Med19951415170717237481205
   PubMed Web of Science ®Google Scholar
• O’BrienRMA caution regarding rules of thumb for variance inflation factorsQual Quant200741673680
   Web of Science ®Google Scholar
• SchackmanBRLeffJAPolskyDCost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary careJ Gen Intern Med201227666967622215271
   PubMed Web of Science ®Google Scholar
• Medicaid and CHIP Payment Access Commission (MACPAC)Medicaid and the Opioid Epidemic2017 Available from: https://www.macpac.gov/publication/medicaid-and-the-opioid-epidemic/Accessed August 30, 2017
   Google Scholar
• Center for Substance Abuse Treatment (CSAT) [webpage on the Internet]Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid AddictionTreatment Improvement Protocol (TIP) Series 40Rockville, MDSubstance Abuse and Mental Health Services Administration2004DHS Publication No (SMA) 04-3939
   Google Scholar
• KuleszaMLarimerMERaoDSubstance use related stigma: what we now and the way forwardJ Addict Behav Ther Rehabil20132278225401117
   PubMedGoogle Scholar
• RoughKBatemanBTPatornoESuppression of substance abuse claims in Medicaid data and rates of diagnoses for non-substance abuse conditionsJAMA2016315111164116626978213
   PubMed Web of Science ®Google Scholar
• O’MalleyKJCookKFPriceMDWildesKRHurdleJFAshtonCMMeasuring diagnoses: ICD Code accuracyHealth Serv Res2005405 pt 21620163916178999
   PubMed Web of Science ®Google Scholar
• KimHMSmithEGStanoCMValidation of key behaviorally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco useBMC Health Serv Res2012121822270080
   PubMed Web of Science ®Google Scholar